ClearPoint Neuro (CLPT)
(Delayed Data from NSDQ)
$6.13 USD
-0.07 (-1.13%)
Updated May 20, 2024 04:00 PM ET
2-Buy of 5 2
D Value C Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 38% (94 out of 248)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.57 | 9.99 |
Current Quarter Estimate | -0.18 | 3.93 | 57.00 |
Year Ago Quarter Estimate | -0.29 | 3.85 | 52.54 |
Next Quarter Estimate | -0.15 | 3.92 | 61.00 |
Next Year Estimate | -0.58 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 30.00 | 13.60 | 15.67 |
Next Year | 7.94 | 22.50 | 9.31 |
Last 5 Years | -256.90 | 9.90 | 8.10 |
Next 5 Years | NA | 15.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 29.13 |
Price/Book (MRQ) | 4.80 | 2.43 |
Price/Cash Flow (MRFY) | NA | 17.85 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -78.84% | -27.75% |
Return on Equity (TTM) | -76.92% | -24.89% |
Debt to Equity (MRQ) | 0.00 | 8.44 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.